CompuGroup Medical SE KGaA 관리
관리 기준 확인 2/4
CompuGroup Medical SE KGaA CEO는 Daniel Gotthardt, Sep2024 에 임명되었습니다 의 임기는 1년 미만입니다. 는 € 50.28M 가치에 해당하는 회사 주식의 6.92% 직접 소유합니다. 50.28M. 경영진과 이사회의 평균 재임 기간은 각각 2 년과 3.8 년입니다.
주요 정보
Daniel Gotthardt
최고 경영자
n/a
총 보상
| CEO 급여 비율 | n/a |
| CEO 임기 | less than a year |
| CEO 소유권 | 6.9% |
| 경영진 평균 재임 기간 | 2yrs |
| 이사회 평균 재임 기간 | 3.8yrs |
최근 관리 업데이트
Recent updates
CompuGroup Medical SE & Co. KGaA's (ETR:COP) Popularity With Investors Is Clear
Nov 08
Here's What's Concerning About CompuGroup Medical SE KGaA's (ETR:COP) Returns On Capital
Sep 06Here's Why CompuGroup Medical SE KGaA (ETR:COP) Has A Meaningful Debt Burden
Aug 20What You Can Learn From CompuGroup Medical SE & Co. KGaA's (ETR:COP) P/E After Its 34% Share Price Crash
Aug 04CompuGroup Medical SE & Co. KGaA (ETR:COP) Just Reported Earnings, And Analysts Cut Their Target Price
Jul 18Is It Too Late To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Jul 15Investors Still Waiting For A Pull Back In CompuGroup Medical SE & Co. KGaA (ETR:COP)
Jun 11The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence
May 24Earnings Release: Here's Why Analysts Cut Their CompuGroup Medical SE & Co. KGaA (ETR:COP) Price Target To €43.20
May 11CompuGroup Medical SE KGaA (ETR:COP) Will Pay A Larger Dividend Than Last Year At €1.00
Apr 27CompuGroup Medical SE KGaA's (ETR:COP) Upcoming Dividend Will Be Larger Than Last Year's
Apr 12We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Mar 20CompuGroup Medical SE & Co. KGaA (ETR:COP) Shares Could Be 49% Below Their Intrinsic Value Estimate
Feb 08Investors Interested In CompuGroup Medical SE & Co. KGaA's (ETR:COP) Earnings
Jan 25Is It Time To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Jan 12The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence
Dec 28We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Dec 15Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Potentially Undervalued?
Oct 09CompuGroup Medical SE KGaA (ETR:COP) Could Be Struggling To Allocate Capital
Sep 22Do CompuGroup Medical SE KGaA's (ETR:COP) Earnings Warrant Your Attention?
Sep 07Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 33% Discount?
Aug 23Here's Why CompuGroup Medical SE KGaA (ETR:COP) Can Manage Its Debt Responsibly
Jul 13At €46.82, Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Worth Looking At Closely?
Jun 24CompuGroup Medical SE KGaA (ETR:COP) Is Reinvesting At Lower Rates Of Return
May 27CompuGroup Medical SE KGaA (ETR:COP) Has Announced A Dividend Of €0.50
May 11Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 32% Discount?
May 06We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Apr 06What Does CompuGroup Medical SE & Co. KGaA's (ETR:COP) Share Price Indicate?
Mar 07Be Wary Of CompuGroup Medical SE KGaA (ETR:COP) And Its Returns On Capital
Feb 06An Intrinsic Calculation For CompuGroup Medical SE & Co. KGaA (ETR:COP) Suggests It's 28% Undervalued
Jan 21These 4 Measures Indicate That CompuGroup Medical SE KGaA (ETR:COP) Is Using Debt Reasonably Well
Jan 05Is Now An Opportune Moment To Examine CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Dec 06CompuGroup Medical SE KGaA (ETR:COP) May Have Issues Allocating Its Capital
Oct 27Are Investors Undervaluing CompuGroup Medical SE & Co. KGaA (ETR:COP) By 49%?
Oct 12At €39.20, Is It Time To Put CompuGroup Medical SE & Co. KGaA (ETR:COP) On Your Watch List?
Sep 04CompuGroup Medical SE KGaA (ETR:COP) Has A Pretty Healthy Balance Sheet
Aug 04Here's What's Concerning About CompuGroup Medical SE KGaA's (ETR:COP) Returns On Capital
Jul 16When Should You Buy CompuGroup Medical SE & Co. KGaA (ETR:COP)?
May 31CEO
Daniel Gotthardt (51 yo)
less than a year
테뉴어
€60,000
보상
Dr. Daniel Gotthardt is MD & CEO of CompuGroup Medical SE & Co. KGaA since September 1, 2024 and had been its Chief Medical Officer since 2023 until September 2024 and was its Senior Vice President from 20...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| MD of Impatient & Social Care and Member of the Management Board | 6yrs | €1.77m | 0.0077% € 56.2k | |
| MD of Ambulatory Information Systems Europe & Member of Management Board | 3yrs | €690.00k | 0.0014% € 9.8k | |
| MD of Ambulatory Information Systems DACH & Member of the Management Board | less than a year | €2.40m | 0.00057% € 4.1k | |
| MD & CEO | less than a year | €60.00k | 6.92% € 50.3m | |
| MD, CFO & Member of Management Board | less than a year | 데이터 없음 | 데이터 없음 | |
| Corporate Vice President of Investor Relations | no data | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Connectivity | 4.8yrs | 데이터 없음 | 데이터 없음 |
2.0yrs
평균 재임 기간
50.5yo
평균 연령
경험이 풍부한 관리: COP 의 관리팀은 경험 ( 2 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Chairman of Supervisory Board | 4.4yrs | €100.00k | 데이터 없음 | |
| Member of Medical Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Independent Member of Supervisory Board | 4.4yrs | €48.00k | 데이터 없음 | |
| Member of Supervisory Board | 4.4yrs | €40.00k | 데이터 없음 | |
| Member of Supervisory Board | 4.4yrs | €60.00k | 0.0025% € 18.2k | |
| Member of Supervisory Board | 4.4yrs | €40.00k | 0.015% € 112.4k | |
| Employee Representative Member of Supervisory Board | 3.2yrs | €50.00k | 데이터 없음 | |
| Employee Representative Member of Supervisory Board | 3.2yrs | €40.00k | 0.000070% € 508.8 | |
| Employee Representative Member of Supervisory Board | 3.2yrs | €50.00k | 데이터 없음 | |
| Vice Chairman of the Supervisory Board | 3.2yrs | €60.00k | 0.000050% € 363.4 | |
| Employee Representative Member of Supervisory Board | 3.8yrs | €40.00k | 데이터 없음 | |
| Member of Supervisory Board | 1.7yrs | €34.00k | 0.00039% € 2.8k |
3.8yrs
평균 재임 기간
57yo
평균 연령
경험이 풍부한 이사회: COP 의 이사회는 경험(평균 재직 기간 3.8 년)으로 간주됩니다.